FDA Inspection
AnMed Health Blood BankAnMed Health Blood Bank – FDA Inspection, Jun 22, 2015
Record Details
This FDA Inspection record concerns AnMed Health Blood Bank, with an inspection on June 22, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- AnMed Health Blood Bank
- Inspection Date
- June 22, 2015
- Product Type
- Biologics
View Company Profile
ID · ce5e829e-a801-4a18-a2fe-81f6091e9875
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 933381
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of AnMed Health Blood Bank
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 22, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 20, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 22, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 1, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for AnMed Health Blood Bank
- FDA Inspection 1233720 - 2024-02-22
- FDA Inspection 1114202 - 2019-11-20
- FDA Inspection 1026004 - 2017-09-15
- FDA Inspection 833700 - 2013-05-22
- FDA Inspection 707621 - 2011-02-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.